<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0320">
 <label>64</label>
 <element-citation publication-type="journal" id="sbref0320">
  <person-group person-group-type="author">
   <name>
    <surname>Flynn</surname>
    <given-names>N.M.</given-names>
   </name>
   <name>
    <surname>Forthal</surname>
    <given-names>D.N.</given-names>
   </name>
   <name>
    <surname>Harro</surname>
    <given-names>C.D.</given-names>
   </name>
   <name>
    <surname>Judson</surname>
    <given-names>F.N.</given-names>
   </name>
   <name>
    <surname>Mayer</surname>
    <given-names>K.H.</given-names>
   </name>
   <name>
    <surname>Para</surname>
    <given-names>M.F.</given-names>
   </name>
  </person-group>
  <article-title>Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection</article-title>
  <source>J. Infect. Dis.</source>
  <volume>191</volume>
  <issue>5</issue>
  <year>2005</year>
  <fpage>654</fpage>
  <lpage>665</lpage>
  <pub-id pub-id-type="pmid">15688278</pub-id>
 </element-citation>
</ref>
